β¨ Education and Health Notices
10 OCTOBER 2013 NEW ZEALAND GAZETTE, No. 140 3805
Private Schools Conditional Integration Act 1975
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Education, Curriculum and Performance, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
St John the Evangelist Catholic School, Otara (1491).
The said supplementary integration agreement was executed on 8 October 2013.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public via the following email address:
enquiries.auckland@minedu.govt.nz
Dated at Wellington this 8th day of October 2013.
MARILYN SCOTT, Group Manager, Education, Curriculum and Performance.
go6556
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Amisulpride
Active Ingredient: Amisulpride 50mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
Product: Apo-Amisulpride
Active Ingredient: Amisulpride 100mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
Product: Apo-Amisulpride
Active Ingredient: Amisulpride 200mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
Product: Apo-Amisulpride
Active Ingredient: Amisulpride 400mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
Product: Cromo-Fresh
Active Ingredient: Sodium cromoglicate 20mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Ursapharm Arzneimittel GmbH, Saarbrucken, Germany
Product: m-Clopidogrel
Active Ingredient: Clopidogrel besilate 112.1mg equivalent to Clopidogrel 75mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturers:
- Pharmathen SA, Attiki, Greece
- Boehringer Ingelheim Ellas A E, Koropi, Greece
- Pharmathen International S A, Rodopi, Greece
Next Page →
β¨ LLM interpretation of page content
π Supplementary Integration Agreement for St John the Evangelist Catholic School
π Education, Culture & Science8 October 2013
Private Schools, Conditional Integration, Supplementary Agreement, Otara
- MARILYN SCOTT, Group Manager, Education, Curriculum and Performance
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act, New Medicines, Distribution Consent, Pharmaceuticals
- Minister of Health
NZ Gazette 2013, No 140